Diclofenac Sodium Topical Gel
Product Images NDC 51316-804

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 28 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium Topical (NDC 51316-804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cvs Woonsocket Prescription Center, Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Leaflet Image 1 (Leaflet Image 1)

FDA Label Image

Leaflet Image 10 (Leaflet Image 10)

FDA Label Image

Leaflet Image 11 (Leaflet Image 11)

FDA Label Image

Leaflet Image 12 (Leaflet Image 12)

FDA Label Image

Leaflet Image 13 (Leaflet Image 13)

FDA Label Image

Leaflet Image 14 (Leaflet Image 14)

FDA Label Image

Leaflet Image 15 (Leaflet Image 15)

FDA Label Image

Leaflet Image 16 (Leaflet Image 16)

FDA Label Image

Leaflet Image 17 (Leaflet Image 17)

FDA Label Image

Leaflet Image 18 (Leaflet Image 18)

FDA Label Image

Leaflet Image 19 (Leaflet Image 19)

FDA Label Image

Leaflet Image 2 (Leaflet Image 2)

FDA Label Image

Leaflet Image 20 (Leaflet Image 20)

FDA Label Image

Leaflet Image 21 (Leaflet Image 21)

FDA Label Image

Leaflet Image 22 (Leaflet Image 22)

FDA Label Image

Leaflet Image 23 (Leaflet Image 23)

FDA Label Image

Leaflet Image 3 (Leaflet Image 3)

FDA Label Image

Leaflet Image 4 (Leaflet Image 4)

FDA Label Image

Leaflet Image 5 (Leaflet Image 5.0.jpg)

FDA Label Image

Leaflet Image 5.1 (Leaflet Image 5.1.jpg)

FDA Label Image

Leaflet Image 6 (Leaflet Image 6.0.jpg)

FDA Label Image

Leaflet Image 6.1 (Leaflet Image 6.1.jpg)

FDA Label Image

Leaflet Image 7 (Leaflet Image 7)

Leaflet Image 7 (Leaflet Image 7)
This is a report showing the correct and incorrect areas on a form, such as hand, knees, and ankles. The correct areas for hand and knee are noted, while the incorrect areas for ankle are also mentioned.*
FDA Label Image

Cvshealth-diclofenac-sodium-topical-carton-image-1.jpg (Cvshealth Diclofenac Sodium Topical Carton Image 1)

Cvshealth-diclofenac-sodium-topical-carton-image-1.jpg (Cvshealth Diclofenac Sodium Topical Carton Image 1)
This text appears to be a description of a topical gel product designed for arthritis pain relief. It is in comparison to Voltaren Arthritis Pain's active ingredient. The gel is meant for daily treatment, anti-inflammatory, and comes in a 5.29 oz (150 g) tube. The product offers a 100% money-back guarantee and is distributed by CVS Pharmacy. The contact information for CVS is also provided.*
FDA Label Image

Cvshealth-diclofenac-sodium-topical-carton-image-2.jpg (Cvshealth Diclofenac Sodium Topical Carton Image 2)

Cvshealth-diclofenac-sodium-topical-carton-image-2.jpg (Cvshealth Diclofenac Sodium Topical Carton Image 2)
Use the enclosed dosing card to measure a dose of Perrigo Diclofenac Sodium Topical Gel 1%. The upper body dose is 0.25 inches long (2 grams). This gel is indicated for arthritis pain, can be used up to 4 times a day, and may take up to 7 days to work. It should be applied to no more than two body areas. It is important not to use the gel if the safety seal on the tube is broken or missing. The gel can be used for up to 21 days unless directed by a doctor. Use it on treatment areas such as the back, hip, or shoulders. This product is for external use only.*
FDA Label Image

Cvshealth-diclofenac-sodium-topical-carton-image-3.jpg (Cvshealth Diclofenac Sodium Topical Carton Image 3)

Cvshealth-diclofenac-sodium-topical-carton-image-3.jpg (Cvshealth Diclofenac Sodium Topical Carton Image 3)
This text provides detailed drug facts and warnings for a product containing diclofenac sodium as the active ingredient. It includes information on the purpose of the drug, usage instructions, warnings about stomach bleeding, heart attack and stroke risks, potential allergic reactions, liver damage, and advice on when to ask a doctor before use. The warning signs, such as stomach bleeding symptoms, are listed, along with specific conditions that may interact negatively with the medication. The text also advises against use in certain age groups, during pregnancy or breastfeeding, and emphasizes the importance of seeking medical help for various symptoms or reactions. It further highlights precautions for contact with eyes, nose, and mouth, and provides guidance on what to do in case of accidental ingestion or worsening pain.*
FDA Label Image

Dosing-card-lower (Dosing Card Lower)

FDA Label Image

Dosing-card-upper (Dosing Card Upper)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.